Back to Trades
Sell4
RECURSION PHARMACEUTICALS, INC.
RXRX
Total Value
$548.6K
Sales
$548.6K
1 transaction
Company Information
- Company Name
- RECURSION PHARMACEUTICALS, INC.
- Ticker Symbol
- RXRX
- CIK
- 0001601830
Insider Information
- Name
- Khan Najat
- Role
- Chief R&D Commercial Officer, Director
- Location
- SALT LAKE CITY, UT
Filing Details
- Filing Date
- Dec 29, 2025
- Transaction Date
- Dec 22, 2025
- Accession Number
- 0001601830-25-000176
- Form Type
- 4